nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—ATIC—pes—type 2 diabetes mellitus	0.0371	0.193	CbGeAlD
Pemetrexed—ATIC—leg—type 2 diabetes mellitus	0.0189	0.0983	CbGeAlD
Pemetrexed—ATIC—hindlimb—type 2 diabetes mellitus	0.0169	0.0878	CbGeAlD
Pemetrexed—GART—islet of Langerhans—type 2 diabetes mellitus	0.00733	0.0381	CbGeAlD
Pemetrexed—GART—nephron tubule—type 2 diabetes mellitus	0.0059	0.0307	CbGeAlD
Pemetrexed—GART—cardiovascular system—type 2 diabetes mellitus	0.0053	0.0275	CbGeAlD
Pemetrexed—GART—kidney—type 2 diabetes mellitus	0.00519	0.027	CbGeAlD
Pemetrexed—GART—pancreas—type 2 diabetes mellitus	0.00515	0.0268	CbGeAlD
Pemetrexed—GART—cortex of kidney—type 2 diabetes mellitus	0.00505	0.0262	CbGeAlD
Pemetrexed—GART—adipose tissue—type 2 diabetes mellitus	0.00468	0.0243	CbGeAlD
Pemetrexed—ATIC—retina—type 2 diabetes mellitus	0.00426	0.0221	CbGeAlD
Pemetrexed—ATIC—cardiovascular system—type 2 diabetes mellitus	0.0036	0.0187	CbGeAlD
Pemetrexed—ATIC—kidney—type 2 diabetes mellitus	0.00352	0.0183	CbGeAlD
Pemetrexed—Tetrahydrofolic acid—MTR—type 2 diabetes mellitus	0.00352	0.316	CrCbGaD
Pemetrexed—ATIC—pancreas—type 2 diabetes mellitus	0.0035	0.0182	CbGeAlD
Pemetrexed—GART—liver—type 2 diabetes mellitus	0.00328	0.017	CbGeAlD
Pemetrexed—ATIC—adipose tissue—type 2 diabetes mellitus	0.00318	0.0165	CbGeAlD
Pemetrexed—SLC29A1—islet of Langerhans—type 2 diabetes mellitus	0.00303	0.0157	CbGeAlD
Pemetrexed—TYMS—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00292	1	CbGdCrCtD
Pemetrexed—DCK—islet of Langerhans—type 2 diabetes mellitus	0.00289	0.015	CbGeAlD
Pemetrexed—DHFR—retina—type 2 diabetes mellitus	0.00286	0.0148	CbGeAlD
Pemetrexed—TYMS—nephron tubule—type 2 diabetes mellitus	0.00272	0.0141	CbGeAlD
Pemetrexed—DHFR—nephron tubule—type 2 diabetes mellitus	0.00269	0.014	CbGeAlD
Pemetrexed—SLC46A1—liver—type 2 diabetes mellitus	0.00266	0.0138	CbGeAlD
Pemetrexed—DCK—retina—type 2 diabetes mellitus	0.00247	0.0128	CbGeAlD
Pemetrexed—DHFR—cardiovascular system—type 2 diabetes mellitus	0.00242	0.0126	CbGeAlD
Pemetrexed—DHFR—kidney—type 2 diabetes mellitus	0.00237	0.0123	CbGeAlD
Pemetrexed—DCK—nephron tubule—type 2 diabetes mellitus	0.00233	0.0121	CbGeAlD
Pemetrexed—TYMS—cortex of kidney—type 2 diabetes mellitus	0.00233	0.0121	CbGeAlD
Pemetrexed—DHFR—cortex of kidney—type 2 diabetes mellitus	0.0023	0.012	CbGeAlD
Pemetrexed—ATIC—liver—type 2 diabetes mellitus	0.00223	0.0116	CbGeAlD
Pemetrexed—SLC29A1—cardiovascular system—type 2 diabetes mellitus	0.00219	0.0114	CbGeAlD
Pemetrexed—TYMS—adipose tissue—type 2 diabetes mellitus	0.00215	0.0112	CbGeAlD
Pemetrexed—SLC29A1—kidney—type 2 diabetes mellitus	0.00214	0.0111	CbGeAlD
Pemetrexed—DHFR—adipose tissue—type 2 diabetes mellitus	0.00213	0.0111	CbGeAlD
Pemetrexed—SLC29A1—pancreas—type 2 diabetes mellitus	0.00213	0.0111	CbGeAlD
Pemetrexed—SLC29A1—cortex of kidney—type 2 diabetes mellitus	0.00209	0.0108	CbGeAlD
Pemetrexed—DCK—pancreas—type 2 diabetes mellitus	0.00203	0.0106	CbGeAlD
Pemetrexed—DCK—cortex of kidney—type 2 diabetes mellitus	0.00199	0.0104	CbGeAlD
Pemetrexed—SLC29A1—adipose tissue—type 2 diabetes mellitus	0.00193	0.01	CbGeAlD
Pemetrexed—DCK—adipose tissue—type 2 diabetes mellitus	0.00185	0.00958	CbGeAlD
Pemetrexed—Leucovorin—ABCC2—type 2 diabetes mellitus	0.00162	0.145	CrCbGaD
Pemetrexed—TYMS—liver—type 2 diabetes mellitus	0.00151	0.00785	CbGeAlD
Pemetrexed—DHFR—liver—type 2 diabetes mellitus	0.0015	0.00777	CbGeAlD
Pemetrexed—SLC29A1—liver—type 2 diabetes mellitus	0.00135	0.00704	CbGeAlD
Pemetrexed—DCK—liver—type 2 diabetes mellitus	0.00129	0.00672	CbGeAlD
Pemetrexed—Folic Acid—MTHFR—type 2 diabetes mellitus	0.0012	0.108	CrCbGaD
Pemetrexed—Tetrahydrofolic acid—MTHFR—type 2 diabetes mellitus	0.0012	0.108	CrCbGaD
Pemetrexed—Tetrahydrofolic acid—ABCC2—type 2 diabetes mellitus	0.00104	0.0937	CrCbGaD
Pemetrexed—Methotrexate—MTHFR—type 2 diabetes mellitus	0.000824	0.074	CrCbGaD
Pemetrexed—Folic Acid—CYP2E1—type 2 diabetes mellitus	0.000732	0.0657	CrCbGaD
Pemetrexed—Methotrexate—ABCC2—type 2 diabetes mellitus	0.000714	0.0641	CrCbGaD
Pemetrexed—Vomiting—Glipizide—type 2 diabetes mellitus	0.000357	0.000791	CcSEcCtD
Pemetrexed—Syncope—Metformin—type 2 diabetes mellitus	0.000356	0.000791	CcSEcCtD
Pemetrexed—Oedema—Valsartan—type 2 diabetes mellitus	0.000356	0.00079	CcSEcCtD
Pemetrexed—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000356	0.00079	CcSEcCtD
Pemetrexed—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000355	0.000788	CcSEcCtD
Pemetrexed—Infection—Valsartan—type 2 diabetes mellitus	0.000354	0.000785	CcSEcCtD
Pemetrexed—Rash—Glipizide—type 2 diabetes mellitus	0.000354	0.000785	CcSEcCtD
Pemetrexed—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000353	0.000784	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000353	0.000784	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000353	0.000783	CcSEcCtD
Pemetrexed—Erythema—Losartan—type 2 diabetes mellitus	0.000353	0.000783	CcSEcCtD
Pemetrexed—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000352	0.000781	CcSEcCtD
Pemetrexed—Oedema—Orlistat—type 2 diabetes mellitus	0.000352	0.000781	CcSEcCtD
Pemetrexed—Shock—Valsartan—type 2 diabetes mellitus	0.000351	0.000777	CcSEcCtD
Pemetrexed—Infection—Orlistat—type 2 diabetes mellitus	0.00035	0.000776	CcSEcCtD
Pemetrexed—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000349	0.000775	CcSEcCtD
Pemetrexed—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000349	0.000775	CcSEcCtD
Pemetrexed—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000349	0.000774	CcSEcCtD
Pemetrexed—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000348	0.000771	CcSEcCtD
Pemetrexed—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000347	0.000769	CcSEcCtD
Pemetrexed—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000346	0.000768	CcSEcCtD
Pemetrexed—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000346	0.000767	CcSEcCtD
Pemetrexed—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000346	0.000767	CcSEcCtD
Pemetrexed—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000346	0.000767	CcSEcCtD
Pemetrexed—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000345	0.000766	CcSEcCtD
Pemetrexed—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000345	0.000766	CcSEcCtD
Pemetrexed—Hypertension—Metformin—type 2 diabetes mellitus	0.000343	0.000761	CcSEcCtD
Pemetrexed—Urticaria—Glyburide—type 2 diabetes mellitus	0.000343	0.000761	CcSEcCtD
Pemetrexed—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000342	0.000758	CcSEcCtD
Pemetrexed—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000341	0.000757	CcSEcCtD
Pemetrexed—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000341	0.000757	CcSEcCtD
Pemetrexed—Anorexia—Valsartan—type 2 diabetes mellitus	0.00034	0.000753	CcSEcCtD
Pemetrexed—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000339	0.000752	CcSEcCtD
Pemetrexed—Chest pain—Metformin—type 2 diabetes mellitus	0.000338	0.000751	CcSEcCtD
Pemetrexed—Myalgia—Metformin—type 2 diabetes mellitus	0.000338	0.000751	CcSEcCtD
Pemetrexed—Syncope—Irbesartan—type 2 diabetes mellitus	0.000336	0.000746	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000336	0.000745	CcSEcCtD
Pemetrexed—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000336	0.000745	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000335	0.000742	CcSEcCtD
Pemetrexed—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000334	0.000741	CcSEcCtD
Pemetrexed—Nausea—Glipizide—type 2 diabetes mellitus	0.000333	0.000739	CcSEcCtD
Pemetrexed—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000333	0.000738	CcSEcCtD
Pemetrexed—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000332	0.000736	CcSEcCtD
Pemetrexed—Pain—Gliclazide—type 2 diabetes mellitus	0.000332	0.000735	CcSEcCtD
Pemetrexed—Constipation—Gliclazide—type 2 diabetes mellitus	0.000332	0.000735	CcSEcCtD
Pemetrexed—Rash—Glimepiride—type 2 diabetes mellitus	0.00033	0.000732	CcSEcCtD
Pemetrexed—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00033	0.000732	CcSEcCtD
Pemetrexed—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00033	0.000731	CcSEcCtD
Pemetrexed—Rash—Sitagliptin—type 2 diabetes mellitus	0.000329	0.00073	CcSEcCtD
Pemetrexed—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000329	0.000729	CcSEcCtD
Pemetrexed—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000329	0.000729	CcSEcCtD
Pemetrexed—Anaemia—Losartan—type 2 diabetes mellitus	0.000326	0.000724	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000325	0.00072	CcSEcCtD
Pemetrexed—Oedema—Metformin—type 2 diabetes mellitus	0.000324	0.00072	CcSEcCtD
Pemetrexed—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000324	0.000718	CcSEcCtD
Pemetrexed—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000323	0.000717	CcSEcCtD
Pemetrexed—Infection—Metformin—type 2 diabetes mellitus	0.000322	0.000715	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000321	0.000711	CcSEcCtD
Pemetrexed—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000319	0.000708	CcSEcCtD
Pemetrexed—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000319	0.000708	CcSEcCtD
Pemetrexed—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000319	0.000708	CcSEcCtD
Pemetrexed—Shock—Metformin—type 2 diabetes mellitus	0.000319	0.000708	CcSEcCtD
Pemetrexed—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000318	0.000706	CcSEcCtD
Pemetrexed—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000318	0.000706	CcSEcCtD
Pemetrexed—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000318	0.000705	CcSEcCtD
Pemetrexed—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000318	0.000704	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000317	0.000703	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000317	0.000703	CcSEcCtD
Pemetrexed—Syncope—Losartan—type 2 diabetes mellitus	0.000317	0.000702	CcSEcCtD
Pemetrexed—Leukopenia—Losartan—type 2 diabetes mellitus	0.000316	0.000701	CcSEcCtD
Pemetrexed—Skin disorder—Metformin—type 2 diabetes mellitus	0.000315	0.000699	CcSEcCtD
Pemetrexed—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000314	0.000696	CcSEcCtD
Pemetrexed—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000312	0.000693	CcSEcCtD
Pemetrexed—Nausea—Glimepiride—type 2 diabetes mellitus	0.000311	0.00069	CcSEcCtD
Pemetrexed—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000311	0.000689	CcSEcCtD
Pemetrexed—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00031	0.000688	CcSEcCtD
Pemetrexed—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00031	0.000688	CcSEcCtD
Pemetrexed—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00031	0.000687	CcSEcCtD
Pemetrexed—Asthenia—Glyburide—type 2 diabetes mellitus	0.00031	0.000687	CcSEcCtD
Pemetrexed—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00031	0.000687	CcSEcCtD
Pemetrexed—Anorexia—Metformin—type 2 diabetes mellitus	0.000309	0.000686	CcSEcCtD
Pemetrexed—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000308	0.000683	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000308	0.000682	CcSEcCtD
Pemetrexed—Alopecia—Ramipril—type 2 diabetes mellitus	0.000307	0.000682	CcSEcCtD
Pemetrexed—Fatigue—Valsartan—type 2 diabetes mellitus	0.000307	0.000681	CcSEcCtD
Pemetrexed—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000307	0.00068	CcSEcCtD
Pemetrexed—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000307	0.00068	CcSEcCtD
Pemetrexed—Oedema—Irbesartan—type 2 diabetes mellitus	0.000306	0.000679	CcSEcCtD
Pemetrexed—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000306	0.000679	CcSEcCtD
Pemetrexed—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000306	0.000679	CcSEcCtD
Pemetrexed—Pruritus—Glyburide—type 2 diabetes mellitus	0.000306	0.000678	CcSEcCtD
Pemetrexed—Constipation—Valsartan—type 2 diabetes mellitus	0.000305	0.000676	CcSEcCtD
Pemetrexed—Infection—Irbesartan—type 2 diabetes mellitus	0.000304	0.000675	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000304	0.000674	CcSEcCtD
Pemetrexed—Fatigue—Orlistat—type 2 diabetes mellitus	0.000304	0.000673	CcSEcCtD
Pemetrexed—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000303	0.000671	CcSEcCtD
Pemetrexed—Erythema—Ramipril—type 2 diabetes mellitus	0.000303	0.000671	CcSEcCtD
Pemetrexed—Shock—Irbesartan—type 2 diabetes mellitus	0.000301	0.000668	CcSEcCtD
Pemetrexed—Pain—Orlistat—type 2 diabetes mellitus	0.000301	0.000668	CcSEcCtD
Pemetrexed—Chest pain—Losartan—type 2 diabetes mellitus	0.000301	0.000667	CcSEcCtD
Pemetrexed—Arthralgia—Losartan—type 2 diabetes mellitus	0.000301	0.000667	CcSEcCtD
Pemetrexed—Myalgia—Losartan—type 2 diabetes mellitus	0.000301	0.000667	CcSEcCtD
Pemetrexed—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.0003	0.000666	CcSEcCtD
Pemetrexed—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.0003	0.000666	CcSEcCtD
Pemetrexed—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.0003	0.000665	CcSEcCtD
Pemetrexed—Rash—Bromocriptine—type 2 diabetes mellitus	0.000298	0.000661	CcSEcCtD
Pemetrexed—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000298	0.00066	CcSEcCtD
Pemetrexed—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000297	0.00066	CcSEcCtD
Pemetrexed—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000296	0.000657	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000296	0.000656	CcSEcCtD
Pemetrexed—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000295	0.000655	CcSEcCtD
Pemetrexed—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000292	0.000647	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000291	0.000646	CcSEcCtD
Pemetrexed—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000289	0.000641	CcSEcCtD
Pemetrexed—Oedema—Losartan—type 2 diabetes mellitus	0.000288	0.000639	CcSEcCtD
Pemetrexed—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000288	0.000639	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000288	0.000638	CcSEcCtD
Pemetrexed—Infection—Losartan—type 2 diabetes mellitus	0.000286	0.000635	CcSEcCtD
Pemetrexed—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000286	0.000634	CcSEcCtD
Pemetrexed—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000286	0.000633	CcSEcCtD
Pemetrexed—Shock—Losartan—type 2 diabetes mellitus	0.000283	0.000629	CcSEcCtD
Pemetrexed—Urticaria—Valsartan—type 2 diabetes mellitus	0.000283	0.000628	CcSEcCtD
Pemetrexed—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000283	0.000627	CcSEcCtD
Pemetrexed—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000282	0.000626	CcSEcCtD
Pemetrexed—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000282	0.000625	CcSEcCtD
Pemetrexed—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000282	0.000625	CcSEcCtD
Pemetrexed—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000281	0.000622	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00028	0.000621	CcSEcCtD
Pemetrexed—Fatigue—Metformin—type 2 diabetes mellitus	0.00028	0.00062	CcSEcCtD
Pemetrexed—Urticaria—Orlistat—type 2 diabetes mellitus	0.00028	0.00062	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000279	0.000619	CcSEcCtD
Pemetrexed—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000278	0.000617	CcSEcCtD
Pemetrexed—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000278	0.000617	CcSEcCtD
Pemetrexed—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000278	0.000617	CcSEcCtD
Pemetrexed—Constipation—Metformin—type 2 diabetes mellitus	0.000277	0.000615	CcSEcCtD
Pemetrexed—Methotrexate—ALB—type 2 diabetes mellitus	0.000275	0.0247	CrCbGaD
Pemetrexed—Anorexia—Losartan—type 2 diabetes mellitus	0.000275	0.000609	CcSEcCtD
Pemetrexed—Vomiting—Glyburide—type 2 diabetes mellitus	0.000275	0.000609	CcSEcCtD
Pemetrexed—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000274	0.000608	CcSEcCtD
Pemetrexed—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000273	0.000605	CcSEcCtD
Pemetrexed—Rash—Glyburide—type 2 diabetes mellitus	0.000272	0.000604	CcSEcCtD
Pemetrexed—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000272	0.000603	CcSEcCtD
Pemetrexed—Syncope—Ramipril—type 2 diabetes mellitus	0.000271	0.000602	CcSEcCtD
Pemetrexed—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000271	0.000601	CcSEcCtD
Pemetrexed—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00027	0.000598	CcSEcCtD
Pemetrexed—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000266	0.00059	CcSEcCtD
Pemetrexed—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000266	0.00059	CcSEcCtD
Pemetrexed—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000265	0.000588	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000265	0.000588	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000264	0.000586	CcSEcCtD
Pemetrexed—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000264	0.000585	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000263	0.000582	CcSEcCtD
Pemetrexed—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000262	0.000582	CcSEcCtD
Pemetrexed—Pain—Irbesartan—type 2 diabetes mellitus	0.000262	0.000581	CcSEcCtD
Pemetrexed—Constipation—Irbesartan—type 2 diabetes mellitus	0.000262	0.000581	CcSEcCtD
Pemetrexed—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000259	0.000575	CcSEcCtD
Pemetrexed—Urticaria—Metformin—type 2 diabetes mellitus	0.000258	0.000572	CcSEcCtD
Pemetrexed—Chest pain—Ramipril—type 2 diabetes mellitus	0.000258	0.000572	CcSEcCtD
Pemetrexed—Myalgia—Ramipril—type 2 diabetes mellitus	0.000258	0.000572	CcSEcCtD
Pemetrexed—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000258	0.000572	CcSEcCtD
Pemetrexed—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000257	0.00057	CcSEcCtD
Pemetrexed—Nausea—Glyburide—type 2 diabetes mellitus	0.000257	0.000569	CcSEcCtD
Pemetrexed—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000256	0.000569	CcSEcCtD
Pemetrexed—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000256	0.000569	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000256	0.000568	CcSEcCtD
Pemetrexed—Asthenia—Valsartan—type 2 diabetes mellitus	0.000256	0.000567	CcSEcCtD
Pemetrexed—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000254	0.000563	CcSEcCtD
Pemetrexed—Asthenia—Orlistat—type 2 diabetes mellitus	0.000253	0.00056	CcSEcCtD
Pemetrexed—Pruritus—Valsartan—type 2 diabetes mellitus	0.000252	0.000559	CcSEcCtD
Pemetrexed—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00025	0.000556	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00025	0.000555	CcSEcCtD
Pemetrexed—Pruritus—Orlistat—type 2 diabetes mellitus	0.000249	0.000552	CcSEcCtD
Pemetrexed—Fatigue—Losartan—type 2 diabetes mellitus	0.000248	0.000551	CcSEcCtD
Pemetrexed—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000247	0.000548	CcSEcCtD
Pemetrexed—Oedema—Ramipril—type 2 diabetes mellitus	0.000247	0.000548	CcSEcCtD
Pemetrexed—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000247	0.000547	CcSEcCtD
Pemetrexed—Constipation—Losartan—type 2 diabetes mellitus	0.000246	0.000546	CcSEcCtD
Pemetrexed—Pain—Losartan—type 2 diabetes mellitus	0.000246	0.000546	CcSEcCtD
Pemetrexed—Rash—Gliclazide—type 2 diabetes mellitus	0.000244	0.000542	CcSEcCtD
Pemetrexed—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000244	0.000542	CcSEcCtD
Pemetrexed—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000244	0.000541	CcSEcCtD
Pemetrexed—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000243	0.000539	CcSEcCtD
Pemetrexed—Shock—Ramipril—type 2 diabetes mellitus	0.000243	0.000539	CcSEcCtD
Pemetrexed—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000242	0.000537	CcSEcCtD
Pemetrexed—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000242	0.000537	CcSEcCtD
Pemetrexed—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000242	0.000537	CcSEcCtD
Pemetrexed—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000242	0.000536	CcSEcCtD
Pemetrexed—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000241	0.000534	CcSEcCtD
Pemetrexed—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00024	0.000532	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000236	0.000523	CcSEcCtD
Pemetrexed—Dizziness—Valsartan—type 2 diabetes mellitus	0.000236	0.000523	CcSEcCtD
Pemetrexed—Anorexia—Ramipril—type 2 diabetes mellitus	0.000236	0.000522	CcSEcCtD
Pemetrexed—Dizziness—Orlistat—type 2 diabetes mellitus	0.000233	0.000516	CcSEcCtD
Pemetrexed—Asthenia—Metformin—type 2 diabetes mellitus	0.000233	0.000516	CcSEcCtD
Pemetrexed—Nausea—Gliclazide—type 2 diabetes mellitus	0.00023	0.000511	CcSEcCtD
Pemetrexed—Pruritus—Metformin—type 2 diabetes mellitus	0.00023	0.000509	CcSEcCtD
Pemetrexed—Urticaria—Losartan—type 2 diabetes mellitus	0.000229	0.000508	CcSEcCtD
Pemetrexed—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000228	0.000505	CcSEcCtD
Pemetrexed—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000228	0.000505	CcSEcCtD
Pemetrexed—Vomiting—Valsartan—type 2 diabetes mellitus	0.000227	0.000502	CcSEcCtD
Pemetrexed—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000226	0.0005	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000225	0.000499	CcSEcCtD
Pemetrexed—Rash—Valsartan—type 2 diabetes mellitus	0.000225	0.000498	CcSEcCtD
Pemetrexed—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000224	0.000498	CcSEcCtD
Pemetrexed—Vomiting—Orlistat—type 2 diabetes mellitus	0.000224	0.000496	CcSEcCtD
Pemetrexed—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000222	0.000492	CcSEcCtD
Pemetrexed—Rash—Orlistat—type 2 diabetes mellitus	0.000222	0.000492	CcSEcCtD
Pemetrexed—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000222	0.000492	CcSEcCtD
Pemetrexed—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00022	0.000489	CcSEcCtD
Pemetrexed—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00022	0.000487	CcSEcCtD
Pemetrexed—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000217	0.000482	CcSEcCtD
Pemetrexed—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000217	0.00048	CcSEcCtD
Pemetrexed—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000215	0.000476	CcSEcCtD
Pemetrexed—Dizziness—Metformin—type 2 diabetes mellitus	0.000215	0.000476	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000213	0.000473	CcSEcCtD
Pemetrexed—Fatigue—Ramipril—type 2 diabetes mellitus	0.000213	0.000472	CcSEcCtD
Pemetrexed—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000212	0.000471	CcSEcCtD
Pemetrexed—Nausea—Valsartan—type 2 diabetes mellitus	0.000212	0.000469	CcSEcCtD
Pemetrexed—Constipation—Ramipril—type 2 diabetes mellitus	0.000211	0.000469	CcSEcCtD
Pemetrexed—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000209	0.000465	CcSEcCtD
Pemetrexed—Nausea—Orlistat—type 2 diabetes mellitus	0.000209	0.000464	CcSEcCtD
Pemetrexed—Asthenia—Losartan—type 2 diabetes mellitus	0.000207	0.000458	CcSEcCtD
Pemetrexed—Vomiting—Metformin—type 2 diabetes mellitus	0.000206	0.000457	CcSEcCtD
Pemetrexed—Rash—Metformin—type 2 diabetes mellitus	0.000205	0.000454	CcSEcCtD
Pemetrexed—Dermatitis—Metformin—type 2 diabetes mellitus	0.000204	0.000453	CcSEcCtD
Pemetrexed—Pruritus—Losartan—type 2 diabetes mellitus	0.000204	0.000452	CcSEcCtD
Pemetrexed—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000202	0.000449	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000202	0.000448	CcSEcCtD
Pemetrexed—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000197	0.000437	CcSEcCtD
Pemetrexed—Urticaria—Ramipril—type 2 diabetes mellitus	0.000196	0.000435	CcSEcCtD
Pemetrexed—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000195	0.000433	CcSEcCtD
Pemetrexed—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000195	0.000433	CcSEcCtD
Pemetrexed—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000195	0.000432	CcSEcCtD
Pemetrexed—Rash—Irbesartan—type 2 diabetes mellitus	0.000193	0.000428	CcSEcCtD
Pemetrexed—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000193	0.000428	CcSEcCtD
Pemetrexed—Nausea—Metformin—type 2 diabetes mellitus	0.000193	0.000427	CcSEcCtD
Pemetrexed—Dizziness—Losartan—type 2 diabetes mellitus	0.000191	0.000423	CcSEcCtD
Pemetrexed—Vomiting—Losartan—type 2 diabetes mellitus	0.000183	0.000406	CcSEcCtD
Pemetrexed—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000182	0.000404	CcSEcCtD
Pemetrexed—Nausea—Irbesartan—type 2 diabetes mellitus	0.000182	0.000403	CcSEcCtD
Pemetrexed—Rash—Losartan—type 2 diabetes mellitus	0.000182	0.000403	CcSEcCtD
Pemetrexed—Dermatitis—Losartan—type 2 diabetes mellitus	0.000182	0.000403	CcSEcCtD
Pemetrexed—Asthenia—Ramipril—type 2 diabetes mellitus	0.000177	0.000393	CcSEcCtD
Pemetrexed—Pruritus—Ramipril—type 2 diabetes mellitus	0.000175	0.000388	CcSEcCtD
Pemetrexed—Nausea—Losartan—type 2 diabetes mellitus	0.000171	0.00038	CcSEcCtD
Pemetrexed—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000169	0.000375	CcSEcCtD
Pemetrexed—Dizziness—Ramipril—type 2 diabetes mellitus	0.000163	0.000362	CcSEcCtD
Pemetrexed—Vomiting—Ramipril—type 2 diabetes mellitus	0.000157	0.000348	CcSEcCtD
Pemetrexed—Rash—Ramipril—type 2 diabetes mellitus	0.000156	0.000345	CcSEcCtD
Pemetrexed—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000156	0.000345	CcSEcCtD
Pemetrexed—Nausea—Ramipril—type 2 diabetes mellitus	0.000147	0.000325	CcSEcCtD
Pemetrexed—DCK—Metabolism—LIPC—type 2 diabetes mellitus	6.92e-05	0.000202	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—HBA1—type 2 diabetes mellitus	6.92e-05	0.000202	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—HMOX1—type 2 diabetes mellitus	6.92e-05	0.000202	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GCK—type 2 diabetes mellitus	6.92e-05	0.000202	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP11A1—type 2 diabetes mellitus	6.87e-05	0.000201	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CALM1—type 2 diabetes mellitus	6.83e-05	0.000199	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CAT—type 2 diabetes mellitus	6.83e-05	0.000199	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTR—type 2 diabetes mellitus	6.81e-05	0.000199	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—APOE—type 2 diabetes mellitus	6.81e-05	0.000199	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MTHFR—type 2 diabetes mellitus	6.8e-05	0.000199	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PCK1—type 2 diabetes mellitus	6.75e-05	0.000197	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SLC9A1—type 2 diabetes mellitus	6.75e-05	0.000197	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—APOA1—type 2 diabetes mellitus	6.73e-05	0.000196	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTGS2—type 2 diabetes mellitus	6.73e-05	0.000196	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALDOB—type 2 diabetes mellitus	6.71e-05	0.000196	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NAMPT—type 2 diabetes mellitus	6.68e-05	0.000195	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CETP—type 2 diabetes mellitus	6.67e-05	0.000195	CbGpPWpGaD
Pemetrexed—DHFR—Disease—GCK—type 2 diabetes mellitus	6.64e-05	0.000194	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—APOB—type 2 diabetes mellitus	6.63e-05	0.000193	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	6.61e-05	0.000193	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IAPP—type 2 diabetes mellitus	6.6e-05	0.000193	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HIF1A—type 2 diabetes mellitus	6.49e-05	0.000189	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	6.48e-05	0.000189	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SLC9A1—type 2 diabetes mellitus	6.48e-05	0.000189	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IRS2—type 2 diabetes mellitus	6.47e-05	0.000189	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PPP2CA—type 2 diabetes mellitus	6.46e-05	0.000189	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTM1—type 2 diabetes mellitus	6.45e-05	0.000188	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CALM1—type 2 diabetes mellitus	6.36e-05	0.000186	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APOE—type 2 diabetes mellitus	6.33e-05	0.000185	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—LPL—type 2 diabetes mellitus	6.33e-05	0.000185	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HK1—type 2 diabetes mellitus	6.32e-05	0.000185	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APOA1—type 2 diabetes mellitus	6.26e-05	0.000183	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—PRKCB—type 2 diabetes mellitus	6.24e-05	0.000182	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GLP1R—type 2 diabetes mellitus	6.24e-05	0.000182	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PSMD6—type 2 diabetes mellitus	6.2e-05	0.000181	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SREBF1—type 2 diabetes mellitus	6.2e-05	0.000181	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SNAP25—type 2 diabetes mellitus	6.2e-05	0.000181	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ADCY5—type 2 diabetes mellitus	6.19e-05	0.000181	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GPX1—type 2 diabetes mellitus	6.17e-05	0.00018	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	6.17e-05	0.00018	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HSD3B2—type 2 diabetes mellitus	6.11e-05	0.000178	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GCKR—type 2 diabetes mellitus	6.11e-05	0.000178	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—KCNJ11—type 2 diabetes mellitus	6.11e-05	0.000178	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—LPA—type 2 diabetes mellitus	6.11e-05	0.000178	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	6.09e-05	0.000178	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CTGF—type 2 diabetes mellitus	6.09e-05	0.000178	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HMGA1—type 2 diabetes mellitus	6.07e-05	0.000177	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—HMGCR—type 2 diabetes mellitus	6.04e-05	0.000176	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CD36—type 2 diabetes mellitus	6.01e-05	0.000176	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PSMD6—type 2 diabetes mellitus	5.95e-05	0.000174	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SNAP25—type 2 diabetes mellitus	5.95e-05	0.000174	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.94e-05	0.000173	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PPARG—type 2 diabetes mellitus	5.93e-05	0.000173	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ADRA2A—type 2 diabetes mellitus	5.91e-05	0.000172	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS2—type 2 diabetes mellitus	5.9e-05	0.000172	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALDOB—type 2 diabetes mellitus	5.85e-05	0.000171	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC2A2—type 2 diabetes mellitus	5.82e-05	0.00017	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—INS—type 2 diabetes mellitus	5.82e-05	0.00017	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CYBA—type 2 diabetes mellitus	5.77e-05	0.000168	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CPT1A—type 2 diabetes mellitus	5.7e-05	0.000167	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—MTR—type 2 diabetes mellitus	5.7e-05	0.000167	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—MTHFR—type 2 diabetes mellitus	5.7e-05	0.000166	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP2E1—type 2 diabetes mellitus	5.67e-05	0.000166	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IRS1—type 2 diabetes mellitus	5.65e-05	0.000165	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SLC2A1—type 2 diabetes mellitus	5.61e-05	0.000164	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP1A2—type 2 diabetes mellitus	5.61e-05	0.000164	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NAMPT—type 2 diabetes mellitus	5.59e-05	0.000163	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PPARA—type 2 diabetes mellitus	5.59e-05	0.000163	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CALCA—type 2 diabetes mellitus	5.58e-05	0.000163	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—LIPC—type 2 diabetes mellitus	5.56e-05	0.000162	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GCK—type 2 diabetes mellitus	5.56e-05	0.000162	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—HBA1—type 2 diabetes mellitus	5.56e-05	0.000162	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP11A1—type 2 diabetes mellitus	5.52e-05	0.000161	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP3A4—type 2 diabetes mellitus	5.47e-05	0.00016	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PRKCB—type 2 diabetes mellitus	5.45e-05	0.000159	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GLP1R—type 2 diabetes mellitus	5.44e-05	0.000159	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC9A1—type 2 diabetes mellitus	5.43e-05	0.000158	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	5.42e-05	0.000158	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AGT—type 2 diabetes mellitus	5.41e-05	0.000158	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—INS—type 2 diabetes mellitus	5.41e-05	0.000158	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SLC2A1—type 2 diabetes mellitus	5.38e-05	0.000157	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SLC2A4—type 2 diabetes mellitus	5.38e-05	0.000157	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GCG—type 2 diabetes mellitus	5.38e-05	0.000157	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CETP—type 2 diabetes mellitus	5.36e-05	0.000157	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ALB—type 2 diabetes mellitus	5.33e-05	0.000156	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CALM1—type 2 diabetes mellitus	5.32e-05	0.000155	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS1—type 2 diabetes mellitus	5.31e-05	0.000155	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—APOE—type 2 diabetes mellitus	5.3e-05	0.000155	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TCF7L2—type 2 diabetes mellitus	5.25e-05	0.000153	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—APOA1—type 2 diabetes mellitus	5.24e-05	0.000153	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT2—type 2 diabetes mellitus	5.23e-05	0.000153	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SLC2A4—type 2 diabetes mellitus	5.16e-05	0.000151	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NOS3—type 2 diabetes mellitus	5.1e-05	0.000149	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3R1—type 2 diabetes mellitus	5.1e-05	0.000149	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC2A2—type 2 diabetes mellitus	5.08e-05	0.000148	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PSMD6—type 2 diabetes mellitus	4.99e-05	0.000146	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SNAP25—type 2 diabetes mellitus	4.99e-05	0.000146	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SREBF1—type 2 diabetes mellitus	4.99e-05	0.000146	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CPT1A—type 2 diabetes mellitus	4.98e-05	0.000145	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MTR—type 2 diabetes mellitus	4.98e-05	0.000145	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SERPINE1—type 2 diabetes mellitus	4.97e-05	0.000145	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CTGF—type 2 diabetes mellitus	4.89e-05	0.000143	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NAMPT—type 2 diabetes mellitus	4.88e-05	0.000143	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HBA1—type 2 diabetes mellitus	4.85e-05	0.000142	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GCK—type 2 diabetes mellitus	4.85e-05	0.000142	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—LIPC—type 2 diabetes mellitus	4.85e-05	0.000142	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—HMGCR—type 2 diabetes mellitus	4.85e-05	0.000142	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2A—type 2 diabetes mellitus	4.85e-05	0.000142	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP11A1—type 2 diabetes mellitus	4.82e-05	0.000141	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—IL6—type 2 diabetes mellitus	4.78e-05	0.00014	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ADRA2A—type 2 diabetes mellitus	4.75e-05	0.000139	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS3—type 2 diabetes mellitus	4.74e-05	0.000139	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3R1—type 2 diabetes mellitus	4.74e-05	0.000139	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC9A1—type 2 diabetes mellitus	4.73e-05	0.000138	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	4.73e-05	0.000138	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CETP—type 2 diabetes mellitus	4.68e-05	0.000137	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—type 2 diabetes mellitus	4.66e-05	0.000136	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.64e-05	0.000135	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GNB3—type 2 diabetes mellitus	4.64e-05	0.000135	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PPARG—type 2 diabetes mellitus	4.62e-05	0.000135	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—HMOX1—type 2 diabetes mellitus	4.62e-05	0.000135	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	4.59e-05	0.000134	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP2E1—type 2 diabetes mellitus	4.56e-05	0.000133	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CAT—type 2 diabetes mellitus	4.55e-05	0.000133	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—INS—type 2 diabetes mellitus	4.53e-05	0.000132	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC2A1—type 2 diabetes mellitus	4.51e-05	0.000132	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP1A2—type 2 diabetes mellitus	4.51e-05	0.000132	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TGFBR2—type 2 diabetes mellitus	4.49e-05	0.000131	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOB—type 2 diabetes mellitus	4.42e-05	0.000129	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP3A4—type 2 diabetes mellitus	4.4e-05	0.000128	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN2B—type 2 diabetes mellitus	4.35e-05	0.000127	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SNAP25—type 2 diabetes mellitus	4.35e-05	0.000127	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SREBF1—type 2 diabetes mellitus	4.35e-05	0.000127	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PSMD6—type 2 diabetes mellitus	4.35e-05	0.000127	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—type 2 diabetes mellitus	4.34e-05	0.000127	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GCG—type 2 diabetes mellitus	4.32e-05	0.000126	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC2A4—type 2 diabetes mellitus	4.32e-05	0.000126	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTM1—type 2 diabetes mellitus	4.3e-05	0.000126	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CTGF—type 2 diabetes mellitus	4.27e-05	0.000125	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOB—type 2 diabetes mellitus	4.24e-05	0.000124	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HMGCR—type 2 diabetes mellitus	4.23e-05	0.000124	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2A—type 2 diabetes mellitus	4.23e-05	0.000124	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—LPL—type 2 diabetes mellitus	4.22e-05	0.000123	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ALB—type 2 diabetes mellitus	4.15e-05	0.000121	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ADRA2A—type 2 diabetes mellitus	4.14e-05	0.000121	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ADCY5—type 2 diabetes mellitus	4.13e-05	0.000121	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GPX1—type 2 diabetes mellitus	4.12e-05	0.00012	CbGpPWpGaD
Pemetrexed—DHFR—Disease—LPL—type 2 diabetes mellitus	4.05e-05	0.000118	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CD36—type 2 diabetes mellitus	4.01e-05	0.000117	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP2E1—type 2 diabetes mellitus	3.98e-05	0.000116	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.97e-05	0.000116	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—NOS3—type 2 diabetes mellitus	3.97e-05	0.000116	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ADCY5—type 2 diabetes mellitus	3.97e-05	0.000116	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPP2CA—type 2 diabetes mellitus	3.96e-05	0.000116	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC2A1—type 2 diabetes mellitus	3.93e-05	0.000115	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP1A2—type 2 diabetes mellitus	3.93e-05	0.000115	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP3A4—type 2 diabetes mellitus	3.84e-05	0.000112	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—MTHFR—type 2 diabetes mellitus	3.8e-05	0.000111	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PPP2CA—type 2 diabetes mellitus	3.8e-05	0.000111	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GCG—type 2 diabetes mellitus	3.77e-05	0.00011	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC2A4—type 2 diabetes mellitus	3.77e-05	0.00011	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CCR5—type 2 diabetes mellitus	3.73e-05	0.000109	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPARA—type 2 diabetes mellitus	3.73e-05	0.000109	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GNB3—type 2 diabetes mellitus	3.73e-05	0.000109	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.73e-05	0.000109	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—HMOX1—type 2 diabetes mellitus	3.71e-05	0.000108	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CAT—type 2 diabetes mellitus	3.66e-05	0.000107	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTHFR—type 2 diabetes mellitus	3.65e-05	0.000106	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.63e-05	0.000106	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AGT—type 2 diabetes mellitus	3.61e-05	0.000105	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOB—type 2 diabetes mellitus	3.55e-05	0.000104	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CALM1—type 2 diabetes mellitus	3.55e-05	0.000104	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOE—type 2 diabetes mellitus	3.54e-05	0.000103	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SRC—type 2 diabetes mellitus	3.51e-05	0.000102	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOA1—type 2 diabetes mellitus	3.5e-05	0.000102	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HIF1A—type 2 diabetes mellitus	3.48e-05	0.000102	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IRS2—type 2 diabetes mellitus	3.47e-05	0.000101	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTM1—type 2 diabetes mellitus	3.46e-05	0.000101	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CALM1—type 2 diabetes mellitus	3.41e-05	9.95e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOE—type 2 diabetes mellitus	3.4e-05	9.91e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—LPL—type 2 diabetes mellitus	3.39e-05	9.9e-05	CbGpPWpGaD
Pemetrexed—GART—Metabolism—AKT1—type 2 diabetes mellitus	3.38e-05	9.87e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOA1—type 2 diabetes mellitus	3.36e-05	9.8e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ADCY5—type 2 diabetes mellitus	3.32e-05	9.7e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GPX1—type 2 diabetes mellitus	3.31e-05	9.66e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GNB3—type 2 diabetes mellitus	3.25e-05	9.49e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.25e-05	9.49e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HMOX1—type 2 diabetes mellitus	3.24e-05	9.45e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CD36—type 2 diabetes mellitus	3.22e-05	9.41e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CAT—type 2 diabetes mellitus	3.19e-05	9.32e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPP2CA—type 2 diabetes mellitus	3.18e-05	9.29e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS2—type 2 diabetes mellitus	3.16e-05	9.24e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TGFB1—type 2 diabetes mellitus	3.14e-05	9.16e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOB—type 2 diabetes mellitus	3.1e-05	9.05e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPARG—type 2 diabetes mellitus	3.08e-05	9e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGFR—type 2 diabetes mellitus	3.08e-05	8.98e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—MTHFR—type 2 diabetes mellitus	3.05e-05	8.92e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IRS1—type 2 diabetes mellitus	3.03e-05	8.84e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—INS—type 2 diabetes mellitus	3.02e-05	8.83e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTM1—type 2 diabetes mellitus	3.02e-05	8.8e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPARA—type 2 diabetes mellitus	3e-05	8.75e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—LPL—type 2 diabetes mellitus	2.96e-05	8.64e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AGT—type 2 diabetes mellitus	2.9e-05	8.47e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—INS—type 2 diabetes mellitus	2.9e-05	8.47e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ADCY5—type 2 diabetes mellitus	2.9e-05	8.46e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GPX1—type 2 diabetes mellitus	2.89e-05	8.43e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CALM1—type 2 diabetes mellitus	2.85e-05	8.33e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOE—type 2 diabetes mellitus	2.84e-05	8.3e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CD36—type 2 diabetes mellitus	2.81e-05	8.21e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOA1—type 2 diabetes mellitus	2.81e-05	8.21e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT2—type 2 diabetes mellitus	2.8e-05	8.19e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPP2CA—type 2 diabetes mellitus	2.78e-05	8.11e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALB—type 2 diabetes mellitus	2.77e-05	8.09e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MTHFR—type 2 diabetes mellitus	2.67e-05	7.78e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SERPINE1—type 2 diabetes mellitus	2.66e-05	7.78e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NOS3—type 2 diabetes mellitus	2.65e-05	7.74e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3R1—type 2 diabetes mellitus	2.65e-05	7.74e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPARA—type 2 diabetes mellitus	2.61e-05	7.63e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS3—type 2 diabetes mellitus	2.54e-05	7.43e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3R1—type 2 diabetes mellitus	2.54e-05	7.43e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AGT—type 2 diabetes mellitus	2.53e-05	7.39e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CALM1—type 2 diabetes mellitus	2.49e-05	7.27e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOE—type 2 diabetes mellitus	2.48e-05	7.24e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPARG—type 2 diabetes mellitus	2.48e-05	7.23e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOA1—type 2 diabetes mellitus	2.45e-05	7.16e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—INS—type 2 diabetes mellitus	2.43e-05	7.09e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—type 2 diabetes mellitus	2.42e-05	7.08e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6—type 2 diabetes mellitus	2.36e-05	6.9e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKT1—type 2 diabetes mellitus	2.34e-05	6.84e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—type 2 diabetes mellitus	2.33e-05	6.79e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALB—type 2 diabetes mellitus	2.23e-05	6.5e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT1—type 2 diabetes mellitus	2.18e-05	6.37e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPARG—type 2 diabetes mellitus	2.16e-05	6.31e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NOS3—type 2 diabetes mellitus	2.13e-05	6.22e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3R1—type 2 diabetes mellitus	2.13e-05	6.22e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—INS—type 2 diabetes mellitus	2.12e-05	6.19e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—type 2 diabetes mellitus	1.95e-05	5.69e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALB—type 2 diabetes mellitus	1.94e-05	5.67e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SRC—type 2 diabetes mellitus	1.88e-05	5.49e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3R1—type 2 diabetes mellitus	1.86e-05	5.43e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NOS3—type 2 diabetes mellitus	1.86e-05	5.43e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKT1—type 2 diabetes mellitus	1.83e-05	5.33e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—type 2 diabetes mellitus	1.7e-05	4.96e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TGFB1—type 2 diabetes mellitus	1.68e-05	4.91e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGFR—type 2 diabetes mellitus	1.65e-05	4.82e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6—type 2 diabetes mellitus	1.27e-05	3.7e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-05	3.56e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT1—type 2 diabetes mellitus	1.17e-05	3.41e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKT1—type 2 diabetes mellitus	9.79e-06	2.86e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKT1—type 2 diabetes mellitus	8.55e-06	2.49e-05	CbGpPWpGaD
